TGFB1 and pachyonychia congenita: The TGF-β-activated kinase 1 (TAK1), a protein kinase essential in the activation of Nuclear Factor-κB (NF-κB), is a downstream target of TGF-β and has been reported to reduce pro-apoptotic pathways and enhance chemoresistance in PC [77,78].